Patents Assigned to SynZyme Technologies, LLC
  • Patent number: 7314633
    Abstract: Carboxylic-gated-nitroxide (CGN) compounds and their esterified derivatives are discovered and disclosed as compositions and shown to have the potential in treating a variety of acute and chronic diseases and disorders resulting from reactive oxygen species (ROS) injury. Compositions for treating tissue damage from ROS injury containing CGN, or active derivatives thereof, in a suitable pharmaceutical, cosmetic, and diagnostic formulations are described.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: January 1, 2008
    Assignee: SynZyme Technologies LLC
    Inventors: Jen-Chang Hsia, Li Ma
  • Patent number: 7229629
    Abstract: Carboxylic-gated-nitroxide (CGN) compounds and their esterified derivatives are discovered and disclosed as compositions and shown to have the potential in treating a variety of acute and chronic diseases and disorders resulting from reactive oxygen species (ROS) injury. Compositions for treating tissue damage from ROS injury containing CGN, or active derivatives thereof, in a suitable pharmaceutical, cosmetic, and diagnostic formulations are described.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: June 12, 2007
    Assignee: SynZyme Technologies, LLC
    Inventors: Jen-Chang Hsia, Li Ma